Literature DB >> 26207398

Antimicrobial Pharmacokinetics and Pharmacodynamics.

Andrew S Jarrell1, Rachel M Kruer1, Dachelle Johnson1, Pamela A Lipsett2.   

Abstract

BACKGROUND: Antimicrobial medications are beneficial when used appropriately, but adverse effects and resistance sometimes limit therapy. These effects may be more problematic with inappropriate antimicrobial use. Consideration of the pharmacokinetic and pharmacodynamic properties of these medications can help optimize drug use.
METHODS: Review of the pertinent English-language literature.
RESULTS: The pharmacokinetic principles of absorption, distribution, metabolism, and elimination determine whether an appropriate dose of medication reaches the intended pathogen. The pharmacodynamic properties of antimicrobial medications define the relation between the drug concentration and its observed effect on the target pathogen. Improvements in clinical outcomes have been observed when antimicrobial agents are dosed optimally according to these properties. In surgical patients, substantial changes in the volume of distribution and elimination necessitate a clear understanding of these principles. Additionally, less adverse drug effects and antimicrobial resistance may occur with optimal use of these drugs.
CONCLUSION: Selecting and dosing antimicrobial medications with consideration of pharmacokinetics and pharmacodynamics may improve patient outcomes and avoid adverse effects.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26207398     DOI: 10.1089/sur.2014.180

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  2 in total

Review 1.  A Review: Antimicrobial Therapy for Human Pythiosis.

Authors:  Sadeep Medhasi; Ariya Chindamporn; Navaporn Worasilchai
Journal:  Antibiotics (Basel)       Date:  2022-03-26

Review 2.  Antimicrobial Activity and Resistance: Influencing Factors.

Authors:  Jun Li; Shuyu Xie; Saeed Ahmed; Funan Wang; Yufeng Gu; Chaonan Zhang; Ximan Chai; Yalan Wu; Jinxia Cai; Guyue Cheng
Journal:  Front Pharmacol       Date:  2017-06-13       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.